Genomic consequences of aberrant DNA repair stratify ovarian cancer histotypes

被引：0
|
作者：
Wang, Yikan
Bashashati, Ali
Anglesio, Michael S.
Cochrane, Dawn
Grewal, Diljot
Horlings, Hugo
Karnezis, Anthony
Mes-Masson, Anne-Marie
Okamoto, Aikou
Yanagida, Satoshi
Yanaihara, Nozomu
Saito, Misato
Gilks, Blake
McAlpine, Jessica
Aparicio, Samuel
Huntsman, David
Shah, Sohrab
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-LB-324
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LB-324
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Aberrant repair of Cr-DNA adducts as a road to genomic instability in chromate carcinogenesis.
    Zhitkovich, Anatoly
    CHEMICAL RESEARCH IN TOXICOLOGY, 2006, 19 (12) : 1700 - 1700
  • [32] Plasma circulating tumor DNA as a genomic biomarker for ovarian cancer
    Nanki, Y.
    George, A. M.
    Chen, Y.
    Brueffer, C.
    Hirasawa, A.
    Chiyoda, T.
    Akahane, T.
    Aoki, D.
    Saal, L. H.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 1670 - 1671
  • [33] Histone Deacetylase Inhibitors Promote Abnormal Binding of DNA Repair Proteins to DNA Double Strand Breaks: Consequences for DNA Repair and Genomic Instability?
    Robert, Carine
    Gojo, Ivana
    Rassool, Feyruz V.
    BLOOD, 2009, 114 (22) : 82 - 82
  • [34] Genomic Instability and Cancer Risk Associated with Erroneous DNA Repair
    Yoshioka, Ken-ichi
    Kusumoto-Matsuo, Rika
    Matsuno, Yusuke
    Ishiai, Masamichi
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (22)
  • [35] Aberrant DNA methylation status of DNA repair genes in breast cancer treated with neoadjuvant chemotherapy
    Watanabe, Yoshiyuki
    Maeda, Ichiro
    Oikawa, Ritsuko
    Wu, Wenwen
    Tsuchiya, Kyoko
    Miyoshi, Yasuo
    Itoh, Fumio
    Tsugawa, Ko-ichiro
    Ohta, Tomohiko
    GENES TO CELLS, 2013, 18 (12) : 1120 - 1130
  • [36] Polycystic Ovary Syndrome, Oligomenorrhea, and Risk of Ovarian Cancer Histotypes: Evidence from the Ovarian Cancer Association Consortium
    Harris, Holly R.
    Babic, Ana
    Webb, Penelope M.
    Nagle, Christina M.
    Jordan, Susan J.
    Risch, Harvey A.
    Rossing, Mary Anne
    Doherty, Jennifer A.
    Goodman, Marc T.
    Modugno, Francesmary
    Ness, Roberta B.
    Moysich, Kirsten B.
    Kjaer, Susanne K.
    Hogdall, Estrid
    Jensen, Allan
    Schildkraut, Joellen M.
    Berchuck, Andrew
    Cramer, Daniel W.
    Bandera, Elisa V.
    Wentzensen, Nicolas
    Kotsopoulos, Joanne
    Narod, Steven A.
    Phelan, Catherine M.
    McLaughlin, John R.
    Anton-Culver, Hoda
    Ziogas, Argyrios
    Pearce, Celeste L.
    Wu, Anna H.
    Terry, Kathryn L.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2018, 27 (02) : 174 - 182
  • [37] Oligomenorrhea, polycystic ovary syndrome, and risk of ovarian cancer histotypes, evidence from the Ovarian Cancer Association Consortium
    Harris, Holly R.
    Jordan, Susan
    Risch, Harvey
    Rossing, Mary Anne
    Goodman, Marc T.
    Modugno, Francesmary
    Kjaer, Susanne Kruger
    Schildkraut, Joellen M.
    Bandera, Elisa V.
    Wentzensen, Nicolas
    Phelan, Catherine
    Anton-Culver, Hoda
    Wu, Anna H.
    Terry, Kathryn L.
    CANCER RESEARCH, 2017, 77
  • [38] DNA REPAIR ENZYME POLYMORPHISM AND RISK OF OVARIAN CANCER IN ISFAHAN
    Dastjerdi, Mehdi Nikbahkt
    ANTICANCER RESEARCH, 2008, 28 (5C) : 3252 - 3252
  • [39] DNA Repair Mutations and Outcomes in Ovarian Cancer-Letter
    Soslow, Robert A.
    CLINICAL CANCER RESEARCH, 2015, 21 (03) : 658 - 658
  • [40] Polymorphisms in DNA repair genes and epithelial ovarian cancer risk
    Auranen, A
    Song, HL
    Waterfall, C
    DiCioccio, RA
    Kuschel, B
    Kjaer, SK
    Hogdall, E
    Hogdall, C
    Stratton, J
    Whittemore, AS
    Easton, DF
    Ponder, BAJ
    Novik, KL
    Dunning, AM
    Gayther, S
    Pharoah, PDP
    INTERNATIONAL JOURNAL OF CANCER, 2005, 117 (04) : 611 - 618
12345